Journal article

Nutritional Complications and the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumors

Erin Laing, Nicole Kiss, Michael Michael, Meinir Krishnasamy

Neuroendocrinology | KARGER | Published : 2020


Neuroendocrine tumors (NETs) have increased in incidence and prevalence over the past 2 decades and affect approximately 170,000 people in the United States alone. Gastroenteropancreatic (GEP) NETs (GEP NET) are a heterogeneous group of rare tumors that have distinct effects on the body due to their tumor location and potential to secrete hormones and peptides. Clinical practice guidelines and consensus guidelines for GEP NETs with regard to best practice for diagnosis, treatment, and medical management are available, but the supportive care needs and optimal nutritional management of patients affected by these unique tumors remain under-researched: evidence to guide clinical practice is lac..

View full abstract


Funding Acknowledgements

This work was supported by funding received from the Victorian Cancer Agency, Victorian Government, Melbourne, Australia; Austin Health, Melbourne, Australia; Ipsen, Australia; and Unicorn Foundation, Australia. E.L. received funding from the Victorian Cancer Agency and Austin Health towards their PhD stipend and research costs. E.L. received funding from Ipsen Australia and Unicorn Foundation Australia towards PhD research costs, not related to this particular manuscript. Funding sources were not involved in the conception, preparation or writing of this manuscript.